Market sentiment signals for Jazz Pharmaceuticals (JAZZ): analyst consensus, short interest, options flow and insider activity.
Analyst Consensus
Buy
27 analysts
Options Flow (P/C)
—
Avg Consensus PT
$263
+13.8%
Highest Price Target
$337
+45.8%
Lowest Price Target
$150
-35.1%
Short Interest
8.6%
Rising — Bearish
Insider Activity (30d)
Net Seller
Short Interest — % of Float
| Date | Firm | Analyst & Accuracy | Upside / Downside | PT Change | Action | Rating |
|---|---|---|---|---|---|---|
| Sep 30, 2026 | Citigroup | Geoff Meacham— | +40.6% | $325 | Initiate | Buy |
| Sep 24, 2026 | Goldman Sachs | Andrea Newkirk— | +45.8% | $337 | Reinstates | Buy |
